Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

× No keyword cloud information.

2 in total

1. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies.

Authors: J L EMMETT; L F GREENE; A PAPANTONIOU
Journal: J Urol Date: 1960-04 Impact factor: 7.450

2. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

Authors: J M Allen; J P O'Shea; K Mashiter; G Williams; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1983-05-21

2 in total

13 in total

1. The first clinical use of depot buserelin for advanced prostatic carcinoma.

Authors: J H Waxman; J Sandow; A Man; M J Barnett; W F Hendry; G M Besser; R T Oliver; P J Magill
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

Review 2. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma.

Authors: R J Santen; A Manni; H Harvey
Journal: Breast Cancer Res Treat Date: 1986 Impact factor: 4.872

3. Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.

Authors: F Labrie; A Dupont; A Belanger; R Lachance; M Giguere
Journal: Br Med J (Clin Res Ed) Date: 1985-08-10

4. Treatment of advanced carcinoma of the prostate.

Authors: G Williams; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1984-09-08

Review 5. Gonadotrophin hormone releasing analogues open new doors in cancer treatment.

Authors: J Waxman
Journal: Br Med J (Clin Res Ed) Date: 1987-10-31

6. Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.

Authors: G Williams; D Kerle; S Griffin; H Dunlop; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1984-12-08

10. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.

Authors: S R Ahmed; J Grant; S M Shalet; A Howell; S D Chowdhury; T Weatherson; N J Blacklock
Journal: Br Med J (Clin Res Ed) Date: 1985-01-19

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.